Postexposure Care and Prophylaxis for Providers. Risk of HIV Infection after Occupational Exposure...
-
Upload
madlyn-montgomery -
Category
Documents
-
view
214 -
download
2
Transcript of Postexposure Care and Prophylaxis for Providers. Risk of HIV Infection after Occupational Exposure...
Postexposure Care and Prophylaxis for Providers
Risk of HIV Infection after Occupational Exposure
If 300 people receive needle-stick or sharp-instrument injuries at their job sites, from an HIV-infected source, how many do you think will be infected with HIV?
• 1 in 300• 10 in 300• 100 in 300
Source: Bell, 1997.
Risk of HIV Infection after Occupational Exposure
If 1000 people had mucous membranes or broken skin exposed to HIV, how many do you think will be infected?
• 1 in 1000• 50 in 1000• 100 in 1000• 200 in 1000
Source: Bell, 1997.
Risk of HIV Infection after Occupational Exposure
What factors do you think might influence whether a provider becomes infected after exposure?
Risk depends on:• Amount of blood on the needle/device • Depth of the injury• Whether needle or device was placed directly
in patient’s artery or vein• Infectious status of source person
Source: CDC, 2005.
Postexposure Care:
Immediately
• Wash injured area with soap and water
• If water is not available, use antiseptic solution to flush area
• If eyes, mouth, or nose are splashed, irrigate with clean water, saline, or sterile irrigation solution
• Do not apply caustic agents (e.g., bleach)
Source: CDC, 2001.
Postexposure Care:
After Providing Immediate Care
continued …
• Evaluate risk of infection based on exposure: – type and amount of contaminated body fluid– type and severity of wound – infectiousness of source patient
• Determine HIV status of source patient, following appropriate counseling and disclosure guidelines
• Provide counseling, HIV testing, PEP treatment, and follow-up care
Source: CDC, 2001 and 2005.
Postexposure Care:
Additional Recommendations
Until status is known:• Avoid donating blood, organs, tissue, semen• Abstain from intercourse or use a condom • Comply with ARV regimen (if accepting therapy)• Obtain counseling for self and partner(s)
If pregnant or breastfeeding, counsel about:• Risk of MTCT (first trimester, maximum risk)• Availability of MTCT drug therapy, side effects• Avoiding breastfeeding until status knownSource: CDC, 2001 and 2005.
ARV Drugs for PEP – Guidelines
• Start as soon as possible• Continue for 4 weeks• Use multidrug therapy – more effective• Conduct routine toxicity tests • Report sudden or severe flu-like symptoms• Conduct antibody tests (baseline, 6 weeks,
12 weeks, and 6 months)
Source: CDC, 2005.
Guidelines for managing PEP should be established.Guidelines for managing PEP should be established.